Thyroxine Sodium 100 mcg contains Levothyroxine Sodium, a synthetic form of the thyroid hormone thyroxine (T4), which plays a vital role in regulating metabolism, growth, and energy balance. It is commonly prescribed for the treatment and management Read More
Ingredient:
Thyroxine Sodium
Dosage Strength:
100 Mcg
Drug Class:
Thyroid Hormone Replacement
Hormone Type:
Synthetic T4
Thyroxine Sodium 100 mcg contains Levothyroxine Sodium, a synthetic form of the thyroid hormone thyroxine (T4), which plays a vital role in regulating metabolism, growth, and energy balance. It is commonly prescribed for the treatment and management of hypothyroidism and related thyroid disorders under the supervision of a qualified healthcare professional. Formulated to deliver consistent potency and reliable absorption, Thyroxine Sodium 100 mcg is manufactured in accordance with pharmaceutical quality standards to ensure uniform dosage in every tablet. This medication is regulated and should be used strictly as prescribed.
| Ingredient | Thyroxine Sodium |
| Dosage Strength | 100 mcg |
| Drug Class | Thyroid hormone replacement |
| Hormone Type | Synthetic T4 |
| Brand | Thyrox |
| Dosage Form | Oral tablet |
| Product Category | Endocrine medication |
| Mechanism | Replaces deficient thyroid hormone |
| Primary Indication | Hypothyroidism treatment |
| Secondary Use | Thyroid suppression therapy |
| Bioavailability | 70–80% oral absorption |
| Target System | Endocrine system |
| Administration Route | Oral |
| Storage | Below 25°C |
| Shelf Life | 24–36 months |
| Packaging Type | Bottle |
| Manufacturer | Various pharmaceutical companies |
| Country Of Origin | Canada |
| Ingredient | Thyroxine Sodium |
| Dosage Strength | 100 mcg |
| Drug Class | Thyroid hormone replacement |
| Hormone Type | Synthetic T4 |
| Brand | Thyrox |
| Dosage Form | Oral tablet |
| Product Category | Endocrine medication |
| Mechanism | Replaces deficient thyroid hormone |
| Primary Indication | Hypothyroidism treatment |
| Secondary Use | Thyroid suppression therapy |
| Bioavailability | 70–80% oral absorption |
| Target System | Endocrine system |
| Administration Route | Oral |
| Storage | Below 25°C |
| Shelf Life | 24–36 months |
| Packaging Type | Bottle |
| Manufacturer | Various pharmaceutical companies |
| Country Of Origin | Canada |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION